期刊文献+

非霍奇金淋巴瘤组织中M_2型巨噬细胞和调节性T细胞含量与其临床特点的关系 被引量:1

Non-Hodgkin's lymphoma tissue type M_2 macrophages and regulatory T cells in the content analysis of the relationship with prognosis
下载PDF
导出
摘要 目的:研究非霍奇金淋巴瘤(NHL)组织中M2型巨噬细胞和调节性T细胞含量与临床特点的关系。方法:对84例经临床及病理确诊的NHL患者采用免疫组化法检测Foxp3和CD163在NHL肿瘤组织中的表达情况,分析Foxp3和CD163阳性细胞绝对数和NHL分期、乳酸脱氢酶水平、是否结外受侵和国际预后指数(IPI)之间的关系。结果:Foxp3和CD163阳性细胞绝对数升高与不同的NHL分期、乳酸脱氢酶水平、是否结外受侵和IPI之间有关。结论:临床上可以通过联合检测NHL患者病理组织中Foxp3和CD163水平监测疾病的发展状况。 Objective: To study the Non-Hodgkin's lymphoma(NHL) in the organization type M2 macro- phages and regulatory T cells in relationship with the prognosis of patients. Methods: A retrospective analysis of 84 patients with NHL pathologic, clinical and follow-up data, using the immunohistochemical method, to detect ex- pression of Foxp3 and CD16a in NHL tumor tissue. The absolute analysis Foxp3 positive cells and NHL stage and lac- tate dehydrogenase levels, whether outside invaded the relationship between the international prognostic index. Re- sults: The absolute levels and different NHL Foxp3 and CD16a positive cells in installment, lactate dehydrogenase levels, whether invaded and international prognostic index between the outside. Foxp3 and CD16a high expression of patients with NHL stage (P 〈0.05), lactate dehydrogenase levels (P 〈0.05), whether the knot invaded (P 〈0. 05) and the international prognostic index (P 〈0.05). Conclusion: Clinical can through joint detection Foxp3 and CD^6a levels in patients with NHL histopathologie evaluation of the prognosis of patients.
出处 《陕西医学杂志》 CAS 2014年第9期1245-1247,共3页 Shaanxi Medical Journal
基金 山东省济宁市课题[济科字(2010)85号]
关键词 非霍奇金淋巴瘤 病理学 巨噬细胞 代谢 Non-Hodgkins lymphoma /Pathology Macrophages/metabolism
  • 相关文献

参考文献5

二级参考文献41

  • 1李丹,李甘地,刘卫平,张文燕,李俸媛,廖殿英.51例原发性结内弥漫性大B细胞淋巴瘤的预后相关因素分析[J].中华血液学杂志,2005,26(4):223-226. 被引量:11
  • 2于慧,洪小南,李进,彭丽萍,叶兰.侵袭性非霍奇金淋巴瘤预后相关因素分析[J].中华肿瘤杂志,2007,29(6):461-463. 被引量:12
  • 3Beyer M, Schultze J L. Reguiatotry T cells in cancer [ J ]. Blood, 2006,108 ( 3 ) :804 - 11.
  • 4Petrulio C A, Kim-Schulze S, Kaufman H L. The tumour microenvi- ronment and implications for cancer immunotherapy [ J ]. Expert Opin Biol Ther,2006,6(7 ) :671 - 84.
  • 5Lech-Maranda E, Bienvenu J, Broussais-Guillaumot F, et al. Plasma TNF-alpha and IL-10 level-based prognostic model predicts out- eome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index[ J]. Arch Immunol Ther Exp (Warsz) ,2010,58(2) :131 -41.
  • 6Stephens G L,Shevaeh E M. FOXP3 + regulatoiy T cells: selfish- ness under scrutiny[J]. Immunity ,2007,27 ( 3 ) :417 - 9.
  • 7Bluestone J A, Abbas A K. Natural versus adaptive regulatory T cells[J].Nat Rev Immunol,2003,3 (3) :253 - 7.
  • 8Sakaguchi S, Ono M,Setoguchi R,et al. FOXP3 + CD25^+ CD4^+ natural regulatory T cells in dominant self-tolerance and autoim- mune disease[ J]. Immunol Rev,2006 ,212 :8 - 27.
  • 9Banham A H,Powrie F M Suri-Paver E,et al. FOXP3^ + regulatory T cells: Current controversies and future perspectives [ J ]. Eur J Immunol,2006,36 ( 11 ) : 2832 - 6.
  • 10Alvaro T, Lejeune M, Salvado M T, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cy- totoxic and regulatory T cells[ J ]. Clin Cancer Res,2005,11 (4) : 1467 - 73.

共引文献23

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部